Abstract
Campylobacter is the leading bacterial cause of gastroenteritis worldwide and its incidence is especially high in low- and middle-income countries (LMIC). Disease epidemiology in LMICs is different compared to high income countries like the USA or in Europe. Children in LMICs commonly have repeated and chronic infections even in the absence of symptoms, which can lead to deficits in early childhood development. In this study, we sequenced and characterized C. jejuni (n=62) from a longitudinal cohort study of children under the age of 5 with and without diarrheal symptoms, and contextualized them within a global C. jejuni genome collection. Epidemiological differences in disease presentation were reflected in the genomes, specifically by the absence of some of the most common global disease-causing lineages. As in many other countries, poultry-associated strains were a major source of human infection but almost half of local disease cases (15 of 31) were attributable to genotypes that are rare outside of Peru. Asymptomatic infection was not limited to a single (or few) human adapted lineages but resulted from phylogenetically divergent strains suggesting an important role for host factors in the cryptic epidemiology of campylobacteriosis in LMICs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
SKS is funded by the Medical Research Council (MR/L015080/1) and BBSRC (BB/P504750/1). Isolate sampling and collection were funded by the National Institute of Health (K01-TW05717) and MK received further support from the Bill & Melinda Gates Foundation (OPP1066146). Whole genome sequencing of the isolates was funded by an EPSRC Bridging the Gaps award (Swansea University). All high-performance computing was performed on MRC CLIMB, funded by the Medical Research Council (MR/L015080/1). Sequencing of global context isolates were previously funded by the Wellcome Trust (088786/C/09/Z). This publication made use of the PubMLST website (http://pubmlst.org/) developed by Keith Jolley and Martin Maiden at the University of Oxford and funded by the Wellcome Trust. No funding agency had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Short read data are available on the NCBI SRA, associated with BioProject PRJNA350267. Assembled genomes and supplementary material are available from FigShare (doi:10.6084/m9.figshare.10352375; individual accession numbers and assembled genome statistics in Table S2).
